Kelly E Dooley

22PUBLICATIONS
64CO-AUTHORS
Gene and molecular therapyEpidemiological methodsPredictive and prognostic markersMedical bacteriologyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Dec 30, 2025
Pharmacokinetics of Twice-daily Tenofovir Alafenamide in Adults With HIV-associated Tuberculosis on Bictegravir/Emtricitabine/Tenofovir Alafenamide and Rifampicin.

Emmanuella Chinonso Osuala, Ivan Nicholas Nkuhairwe, Marothi Peter Letsoalo

|Dec 18, 2025
Efficacy of isoniazid in paediatric tuberculosis: an individual participant data meta-analysis.

Agathe Béranger, Belén P Solans, Ryo Miyakawa

|Jul 30, 2025
Evidence Generation for a Host-Response Biosignature of Respiratory Disease.

Kelly E Dooley, Michael Morimoto, Piotr Kaszuba

|Jun 02, 2025
A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampicin-Resistant Pulmonary Tuberculosis.

Veronique de Jager, Laurynas Mockeliunas, Huifang You

|Jul 16, 2024
Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial.

Ava Y Xu, Gustavo E Velásquez, Nan Zhang

|May 06, 2024
Relationship between HIV viral suppression and multidrug resistant tuberculosis treatment outcomes.

Keri Geiger, Amita Patil, Chakra Budhathoki

Pageof 4

Frequent Collaborators

5 joint publications

Paolo Denti

3 joint publications

Eric Nuermberger

2 joint publications

Veronique De Jager

2 joint publications

Lubbe Wiesner